Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WR 279,396 vs Paromomycin for Cutaneous Leishmaniasis in Peru
NCT01032382Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Jan 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WR 279,396 in cutaneous leishmaniasis (CL), sponsored by U.S. Army Medical Research and Development Command. Started Jan 2010; status: completed.
02
Drugs
WR 279,396
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT01032382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01032382.